Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cost Effectiveness and Resource Allocation
Published in: Cost Effectiveness and Resource Allocation 1/2010

Open Access 01-12-2010 | Review

Can choices between alternative hip prostheses be evidence based? a review of the economic evaluation literature

Authors: Charlotte Davies, Paula Lorgelly, Ian Shemilt, Miranda Mugford, Keith Tucker, Alex MacGregor

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2010

Login to get access

Abstract

Background

Total hip replacement surgery places a considerable financial burden on health services and society. Given the large number of hip prostheses available to surgeons, reliable economic evidence is crucial to inform resource allocation decisions. This review summarises published economic evidence on alternative hip prostheses to examine the potential for the literature to inform resource allocation decisions in the UK.

Methods

We searched nine medical and economics electronic databases. 3,270 studies were initially identified, 17 studies were included in the review. Studies were critically appraised using three separate guidelines.

Results

Several methodological problems were identified including a lack of observed long term prosthesis survival data, limited up-to-date and UK based evidence and exclusion of patient and societal perspectives.

Conclusions

More clinical trials including long term follow-up and economic evaluation are needed. These should compare the cost-effectiveness of different prostheses with longer-term follow-up and including a wider perspective.
Appendix
Available only for authorised users
Literature
1.
2.
National Joint Registry for England and Wales: 6th Annual Report. 2008.
3.
National Audit Office: Hip Replacements: Getting it right first time. Report by the Comptroller and Auditor General 2000
4.
5.
National Institute for Clinical Excellence: Guidance on the selection of prostheses for primary total hip replacement. NICE ed. London; 2000.
6.
Sibanda N, Copley LP, Lewsey JD, Borroff M, Gregg P, MacGregor AJ, Pickford M, Porter M, Tucker K, van der Meulen JH: Steering Comm NJREW: Revision Rates after Primary Hip and Knee Replacement in England between 2003 and 2006. Plos Medicine 2008, 5: 1398–1408.CrossRef
7.
National Joint Registry for England and Wales: 4th Annual Report. 2007.
8.
Briggs A, Sculpher M, Dawson J, Fitzpatrick R, Murray D, Malchau H: The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy 2004, 3: 79–89.PubMedCrossRef
9.
Briggs A, Claxton K, Sculpher M: Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
10.
National Institute for Clinical Excellence: Guide to the Methods of Technology Appraisal. 2008.
11.
12.
Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. Oxford; 2005.
13.
Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein, E, Knapp M, et al.: Incorporating Economics Evidence. In Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons; 2008.
14.
15.
16.
17.
Philips Z, Bojke L, Sculpher M, Claxton K, Golder S: Good practice guidelines for decision-analytic modelling in health technology assessment - A review and consolidation of quality assessment. Pharmacoeconomics 2006, 24: 355–371.PubMedCrossRef
18.
19.
Pynsent PB, Carter SR, Bulstrode CJK: The total cost of hip-joint replacement; a model for purchasers. J Public Health 1996, 18: 157–168.CrossRef
20.
Gillespie WJ, Pekarsky B, O'Connell DL: Evaluation of new technologies for total hip replacement. Economic modelling and clinical trials. J Bone Joint Surg Br 1995, 77-B: 528–533.
21.
Daellenbach HG, Gillespie WJ, Crosbie P, Daellenbach US: Economic appraisal of new technology in the absence of survival data - the case of total hip replacement. Social Science & Medicine 1990, 31: 1287–1293.CrossRef
22.
Baxter K: An economic model to estimate the relative costs over 20 years of different hip prostheses. Journal of Epidemiology & Community Health 1999, 53: 542–547.CrossRef
23.
Faulkner A, Kennedy LG, Baxter K, Donovan J, Wilkinson M, Bevan G: Effectiveness of hip prostheses in primary total hip replacement: a critical review of evidence and an economic model. Health Technology Assessment - NHS R&D HTA Programme 1998., 2:
24.
Fitzpatrick R, Shortall E, Sculpher M, Murray D, Morris R, Lodge M, Dawson J, Carr A, Britton A, Briggs A: Primary total hip replacement surgery: a systematic reviews of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technology Assessment - NHS R&D HTA Programme 1998., 2:
25.
Marinelli MSA, Panfoli N, de Palma L: Cost-effectiveness of cemented versus cementless total hip arthroplasty. A Markov decision analysis based on implant cost. J Orthopaed Traumatol 2008, 9: 23–28.CrossRef
26.
Spiegelhalter DJ, Best NG: Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Statistics in Medicine 2003, 22: 3687–3709.PubMedCrossRef
27.
Givon U, Ginsberg GM, Horoszowski H, Shemer J: Cost-Utility Analysis of Total Hip Arthroplasties: Technology Assessment of Surgical Procedures by Mailed Questionnaires. International Journal of Technology Assessment in Health Care 1998, 14: 735–742.PubMedCrossRef
28.
Unnanuntana A, Dimitroulias A, Bolognesi MP, Hwang KL, Goodman SB, Marcus RE: Cementless Femoral Prostheses Cost More to Implant than Cemented Femoral Prostheses. Clinical Orthopaedics and Related Research 2009, 467: 1546–1551.PubMedCentralPubMedCrossRef
29.
Yates P, Serjeant S, Rushforth G, Middleton R: The relative cost of cemented and uncemented total hip arthroplasties. Journal of Arthroplasty 2006, 21: 102–105.PubMedCrossRef
30.
Scheerlink T, Duquet W, Casteleyn P-P: Socioeconomic aspects of total hip arthroplasty. A one-year survey in a Belgian university hospital. Acta Orthop Belg 2004, 70: 525–533.
31.
Pingsmann A, Muller RT, Goller A: Cost analysis for total hip arthroplasty by measurement of time and material expenditure. Archives of Orthopaedic and Trauma Surgery 1998, 117: 421–424.PubMedCrossRef
32.
Metz CM, Freiberg AA: An international comparative study of total hip arthroplasty cost and practice patterns. Journal of Arthroplasty 1998, 13: 296–298.PubMedCrossRef
33.
Murray DWCAJ, Bulstrode CJ: Which primary total hip replacement? J Bone Joint Surg 1995, 77: 520–527.
34.
Boardman DL, Lieberman JR, Thomas BJ: Impact of declining reimbursement and rising hospital costs on the feasibility of total hip arthroplasty. Journal of Arthroplasty 1997, 12: 526–534.PubMedCrossRef
35.
National Institute for Health and Clinical Excellence: The Guidelines Manual 2009. pp. Appendix H Methadology checklist: economic evaluations; 2009:Appendix H, Methadology checklist: economic evaluations
36.
Maniadakis N, Gray A: Health economics and orthopaedics. J Bone Joint Surg Br 2000, 82-B: 2–8.CrossRef
37.
38.
Donaldson C, Mugford M, Vale L: Evidence-based Health Economics. London: BMJ Books; 2002.
39.
Sculpher M, Drummond M, Buxton M: The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy 1997, 2: 26–30.PubMed
40.
41.
Jameson S, Reed MR: Payment by results and coding practice in the National Health Service: The importance for orthopaedic surgeons. J Bone Joint Surg Br 2007, 89-B: 1427–1430.CrossRef
42.
Department of Health: National Tariff. Department of Health; 2008.
43.
44.
Metadata
Title
Can choices between alternative hip prostheses be evidence based? a review of the economic evaluation literature
Authors
Charlotte Davies
Paula Lorgelly
Ian Shemilt
Miranda Mugford
Keith Tucker
Alex MacGregor
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2010
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-8-20

Other articles of this Issue 1/2010

Cost Effectiveness and Resource Allocation 1/2010 Go to the issue

Research

Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?

Research

Cost-effectiveness implications of GP intervention to promote physical activity: evidence from Perth, Australia

Research

Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach

Research

Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco

Research

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom

Research

To what extent does recurrent government health expenditure in Uganda reflect its policy priorities?